Description

What Is LL-37 Peptide?

LL-37 is a human-derived cathelicidin antimicrobial peptide. Researchers study LL-37 for its ability to combat microbial infections, modulate immune responses, and promote tissue repair. It plays a vital role in experimental research on antimicrobial defense, inflammation regulation, and wound healing.

Mechanism of Action in Research

1. Antimicrobial Activity

• Directly disrupts bacterial and viral cell membranes
• Helps study host defense mechanisms against pathogens
• Evaluated in infection control and microbiology research

2. Immune System Modulation

• Regulates cytokine production and immune signaling pathways
• Supports studies on immune response and inflammation control
• Investigated for autoimmune and inflammatory condition models

3. Wound Healing and Tissue Repair

• Promotes cell migration and angiogenesis in experimental models
• Supports research on tissue regeneration and repair mechanisms
• Studied for potential use in dermatology and regenerative medicine research

Key Research Benefits

• Enhances antimicrobial defense mechanisms
• Supports immune modulation and inflammation research
• Promotes tissue repair and wound healing studies
• Serves as a model peptide in laboratory research for infection and immune response

Research Applications

LL-37 is widely used in laboratory and experimental research for:

• Antimicrobial activity studies
• Immune modulation and inflammation research
• Wound healing and tissue regeneration studies
• Pathogen defense and infection control research

Scientific Insights

LL-37 is a versatile peptide in biomedical research, providing insights into antimicrobial defense, immune regulation, and tissue repair. Its multifunctional properties make it a valuable tool in experimental and laboratory studies.

For Research Use Only
Not intended for human consumption. LL-37 is strictly for scientific and laboratory research purposes.